Keith Gottesdiener, Prime Medicine CEO
Prime Medicine considers focus on autoimmune diseases for CAR-T, CEO says
Prime Medicine is considering developing cell therapies for autoimmune diseases and will likely look for a partner for cancer cell therapies, CEO Keith Gottesdiener said …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.